Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone

Journal of Pediatric Surgery

Volumn 46, Issue 3, 2011, Pages

  Garten, Lars ^a   Degenhardt, Petra ^a   Bührer, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Abdominal su; Bowel dysfunction; Newborn; Opiate receptor antagonist

Indexed keywords

17 METHYLNALTREXONE; 17 METHYLNALTREXONE BROMIDE; FENTANYL; OPIATE;

ABDOMINAL SURGERY; ABSENCE OF SIDE EFFECTS; ANALGESIA; AORTIC ARCH SURGERY; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; CORONARY ARTERY DISEASE; DRUG INDUCED DISEASE; FATALITY; FEMALE; HUMAN; ILEOSTOMY; ILEUS; INTESTINAL DYSMOTILITY; LAPAROTOMY; NECROTIZING ENTEROCOLITIS; NEWBORN; OPIOID INDUCED POSTOPERATIVE ILEUS; POSTOPERATIVE PERIOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPEATED DRUG DOSE;

AORTIC ARCH SYNDROMES; CORONARY DISEASE; EXTRACORPOREAL MEMBRANE OXYGENATION; FATAL OUTCOME; FEMALE; FENTANYL; HUMANS; INFANT, NEWBORN; INTESTINAL PSEUDO-OBSTRUCTION; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; QUATERNARY AMMONIUM COMPOUNDS; REMISSION INDUCTION;

EID: 79952270039     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.10.015     Document Type: Article

References (13)

1. Manara L., Bianchi G., and Ferretti P. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites J Pharmacol Exp Ther 237 3 1986 945 949 (Pubitemid 16088118)
2. Tavani A., Bianchi G., and Ferretti P. Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action Life Sci 27 23 1980 2211 2217 (Pubitemid 11177362)
3. Yuan C.S., Foss J.F., and O'Connor M. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial JAMA 283 3 2000 367 372 (Pubitemid 30051755)
4. Thomas J., Karver S., and Cooney G.A. Methylnaltrexone for opioid-induced constipation in advanced illness N Engl J Med 358 22 2008 2332 2343 (Pubitemid 351749157)
5. Slatkin N., Thomas J., and Lipman A.G. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients J Support Oncol 7 1 2009 39 46
6. Portenoy R.K., Thomas J., and Moehl Boatwright M.L. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study J Pain Symptom Manage 35 5 2008 458 468 (Pubitemid 351601995)
7. Wolff B.G., Weese J.L., and Ludwig K.A. Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection J Am Coll Surg 204 4 2007 609 616 (Pubitemid 46428581)
8. Leslie J.B. Alvimopan for the management of postoperative ileus Ann Pharmacother 39 9 2005 1502 1510 Epub 2005 Aug 2 (Pubitemid 41197132)
9. Kraft M.D. Emerging pharmacologic options for treating postoperative ileus Am J Health Syst Pharm 64 20 Suppl 13 2007 S13 20
10. Hummel P., Puchalski M., and Creech S.D. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain J Perinatol 28 1 2008 55 60
11. Liu M., and Wittbrodt E. Low-dose oral naloxone reverses opioid-induced constipation and analgesia J Pain Symptom Manage 23 1 2002 48 53 (Pubitemid 34093880)
12. Delaney C.P., Wolff B.G., and Viscusi E.R. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies Ann Surg 245 3 2007 355 363 (Pubitemid 46673131)
13. Kraft M.D. Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus Expert Opin Investig Drugs 17 9 2008 1365 1377